ESR1 and breast carcinoma: Estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2) define the prognosis, identify tumors for targeted therapy, and remain the sole established single-molecule biomarkers defining the minimum breast cancer pathology data set [27].